Treatment of symptomatic fibroid disease using uterine fibroid embolisation: An Australian perspective.
fibroids
hysterectomy
leiomyoma
myomectomy
uterine fibroid embolisation
Journal
The Australian & New Zealand journal of obstetrics & gynaecology
ISSN: 1479-828X
Titre abrégé: Aust N Z J Obstet Gynaecol
Pays: Australia
ID NLM: 0001027
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
11
04
2019
accepted:
16
12
2019
pubmed:
21
1
2020
medline:
15
12
2020
entrez:
21
1
2020
Statut:
ppublish
Résumé
Uterine leiomyomata (fibroids) are symptomatic in up to 35% of women and treatment can be a costly burden to the individual and society. Options for treatment range from non-hormonal, hormonal, minimally invasive, to surgery. While symptoms from smaller fibroids may respond to simple treatment, those with larger fibroids or with a large volume of disease require a more definitive option. Surgery (hysterectomy or myomectomy) are both well-established treatment modalities with good clinical outcomes. Since the 1990s, uterine fibroid embolisation has emerged as a less invasive option for women than for surgical techniques, while level 1 evidence shows that in the short to mid-term, there is a similar improvement in symptom-related quality of life outcomes to surgery, but with reduced hospital stay and reduced cost. However, in the longer term there may be a need for further treatment or retreatment in some patients compared with surgery. Since its introduction, uptake of this procedure in Australia has been low relative to surgical options. This manuscript reviews the current literature surrounding treatment, along with the trends in uptake of embolisation by Australian women, places this in context of current guidelines from major societies, and encourages gynaecologists and interventional radiologists to be aware of the advantages and limitations of embolisation.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
324-329Informations de copyright
© 2020 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Références
Stewart EA, Cookson CL, Gandolfo RA et al. Epidemiology of uterine fibroids: a systematic review. BJOG 2017; 124: 1501-1512.
Marsh EE, Ekpo GE, Cardozo ER et al. Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18-30 years old): a pilot study. Fertil Steril 2013; 99: 1951-1957.
Brennan A, Hickey M. Abnormal uterine bleeding: managing endometrial dysfunction and leiomyomas. Med J Aust 2018; 208: 90-95.
Soliman AM, Yang H, Du X et al. The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013. Am J Obstet Gynecol 2015; 213: 141-160.
National Institute for Health and Care Excellence. Heavy Menstrual Bleeding: Assessment and Management. Guideline CG44. Published January 2007. [Accessed 23 February 2019.] Available from URL: https://www.nice.org.uk/
Chittawar PB, Kamath MS. Review of nonsurgical/minimally invasive treatments and open myomectomy for uterine fibroids. Curr Opin Obstet Gynecol 2015; 27: 391-397.
De La Cruz MS, Buchanan EM. Uterine fibroids: diagnosis and treatment. Am Fam Physician 2017; 95: 100-107.
Mirowska-Allen KL, Kong KK, Ang WC. Unplanned hysterectomy following myomectomy at a tertiary institution: a case series and review of the literature. J Endometr Pelvic Pain Disord 2018; 10: 151-157.
Gonsalves C. Uterine artery embolization for treatment of symptomatic fibroids. Semin Intervent Radiol 2008; 25: 369-377.
Yusuf F, Leeder S, Wilson A. Recent estimates of the incidence of hysterectomy in New South Wales and trends over the past 30 years. Aust NZ J Obstet Gynaecol 2016; 56(4): 420-425.
Varol N, Healey M, Tang P et al. Ten-year review of hysterectomy morbidity and mortality: can we change direction? Aust NZ J Obstet Gynaecol 2001; 41: 295-302.
Mara M, Maskova J, Fucikova Z et al. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol 2008; 31(1): 73-85.
Spies JS, Pelage JP. Uterine Artery Embolization and Gynecologic Embolotherapy. Philadelphia, PA: Lippincott Williams & Wilkins, 2005; 3-18.
Ravina JH, Herbreteau D, Ciraru-Vigneron N et al. Arterial embolisation to treat uterine myomata. Lancet 1995; 346: 671-672.
Edwards RD, Moss JG, Lumsden MA, The REST investigators. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 2007; 356: 360-70.
Moss J, Cooper K, Khaund A et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG 2011; 118: 936-944.
Hekenkamp WJK, Volkers NA, Birnie E et al. EMMY trial: a randomised comparison of uterine artery embolisation and hysterectomy for the treatment of symptomatic uterine fibroids. Int Congr Ser 2005; 1279: 179-183.
Van der Kooij SM, Hehenkamp WJK, Volkers NA et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. AJOC 2010; 203: 105-113.
de Bruijn AM, Ankum WM, Reekers J et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. Am J Obstet Gynecol 2016; 215: 745.e1-745.e12.
Gupta JK, Sinha A, Lumsden MA et al. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database of Systematic Reviews 2014; CD005073.
Fonseca MCM, Castro R, Machado M et al. Uterine artery embolization and surgical methods for the treatment of symptomatic uterine leiomyomas: a systematic review and meta-analysis followed by indirect treatment comparison. Clin Ther 2017; 39: 1438-1455.
Desai VB, Wright JD, Gross CP et al. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy. Am J Obstet Gynecol 2019; 221: 39.e1-39.e14.
Goto A, Takeuchi S, Sugimura K et al. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer 2002; 12: 354-361.
Gaylene P, Mocarski E, Bennett J et al. Pregnancy after uterine artery embolization for leiomyomata: the ontario multicenter trial. Obstet Gynecol 2005; 105(1): 67-76.
Torre A, Paillusson B, Fain V et al. Uterine artery embolization for severe symptomatic fibroids: effects on fertility and symptoms. Hum Reprod 2014; 29: 490-501.
Torre A, Fauconnier A, Kahn V et al. Fertility after uterine artery embolization for symptomatic multiple fibroids with no other infertility factors. Eur Radiol 2017; 27: 2850.
Karlsen K, Hrobjartsson A, Korsholm M et al. Fertility after uterine artery embolization of fibroids: a systematic review. Arch Gynecol Obstet 2018; 297: 13.
ACOG Practice Bulletin No. 96: Alternatives to Hysterectomy in the Management of Leiomyomas [Internet]. [Accessed 23 February 2019.] Available from URL: http://www.mintir.com/page/pop_page1.pdf
SOGC Clinical Practice Guideline Number 150 [Internet]. [Accessed 23 February 2019.] Available from URL: https://sogc.org/wp-content/uploads/2015/02/gui318CPG1502ErevB1.pdf
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Uterine Artery Embolisation for the Treatment of Uterine Fibroids. College Statement C-Gyn 23 1st Endorsed: March 2008. [Accessed 20 November 2018.] Available from URL: http://www.ranzcog.edu.au/publications
Medical Services Advisory Committee. Uterine Artery Embolisation for the Treatment of Symptomatic Uterine Fibroids, Assessment Report January 2006. [Accessed 20 November 2018.] Available from URL: http://www.msac.gov.au/
Clements W, Moriarty HK, Koukounaras J et al. The cost to perform uterine fibroid embolisation in the Australian public hospital system. J Med Imaging Radiat Oncol 2019. https://doi.org/10.1111/1754-9485.12982
Australian Government Department of Human Services. Medicare Item Reports [Internet]. [Accessed 20 November 2018.] Available from URL: http://medicarestatistics.humanservices.gov.au/statistics/mbs_item.jsp
Medicare Australia. Medicare Benefits Schedule Book: Category 3. Published January 2018. [Accessed 20 November 2018.] Available from URL: http://www.mbsonline.gov.au/
Liang E, Brown B, Kirsop R et al. Efficacy of uterine artery embolisation for treatment of symptomatic fibroids and adenomyosis - an interim report on an Australian experience. Aust NZ J Obstet Gynaecol 2012; 52: 106-112.